宝莱特：12月29日召开董事会会议

Group 1 - The company Baolait (SZ 300246) announced that its ninth fifth board meeting was held on December 29, 2025, to discuss the proposal regarding not adjusting the conversion price of "Baolai Convertible Bonds" [1] - For the year 2024, Baolait's revenue composition is as follows: medical devices account for 69.34%, commercial activities account for 29.46%, and other businesses account for 1.2% [1] - As of the report, Baolait's market capitalization is 2.2 billion yuan [1] Group 2 - A new type of chip has been developed in China, which bypasses the restrictions on lithography machines and supports AI training and embodied intelligence, capable of mass production using mature processes of 28 nanometers and above [1]